Clinical Report: Nanoparticle LEDs Advance Deep-Tissue Imaging
Overview
A novel method for electrically activating lanthanide-doped nanoparticles (LnNPs) has been developed, enabling low-voltage operation for near-infrared (NIR) light sources. This advancement may enhance diagnostic imaging and sensing systems by providing stable, wavelength-specific NIR light.
Background
The ability to produce stable NIR light sources is crucial for biomedical imaging due to reduced tissue autofluorescence and scattering. Traditional LnNPs require optical excitation, limiting their application in electronic devices. This study presents a significant advancement in making these nanoparticles compatible with low-voltage electronic systems, potentially transforming diagnostic imaging.
Data Highlights
No numerical data or trial data provided in the article.
Key Findings
- Hybrid nanoparticles were created by coating LnNPs with 9-anthracenecarboxylic acid (9-ACA), enabling electrical activation.
- Devices operated at low voltages around 5 V, producing narrow electroluminescence peaks at specific NIR wavelengths.
- Emission bandwidths were narrower than those of many semiconductor-based NIR emitters.
- The study demonstrated efficient triplet energy transfer from the organic ligand to lanthanide ions.
- Device performance can be improved through nanoparticle and device design.
Clinical Implications
The development of electrically driven LnNPs could lead to more compact and efficient NIR light sources for diagnostic and analytical applications. This technology may enhance imaging techniques in clinical settings, particularly in oncology.
Conclusion
This research provides a promising pathway for integrating lanthanide-doped nanoparticles into electronic devices, potentially revolutionizing NIR imaging in clinical diagnostics.
References
- The ASCO Post, Source, 2018 -- New Techniques in Intraoperative-Guided Imagery May Enhance Outcomes in Patients With Cancer
- the pathologist, Source, 2026 -- Can a Pocket Microscope Replace the Stain?
- The ASCO Post, Source, 2014 -- New Imaging Technique Identifies Receptors for Targeted Cancer Therapy
- 2025 Guidelines for Fluorescence Image-guided Surgery Using Indocyanine Green in Gastrointestinal Procedures - A SAGES Publication
- Intraoperative fluorescence angiography with indocyanine green to prevent anastomotic leak in rectal cancer surgery (IntAct): an unblinded randomised controlled trial - ScienceDirect
- NIR-II light in clinical oncology: opportunities and challenges | Nature Reviews Clinical Oncology
- the analytical scientist — Shining a Light on Microplastic Transport in the Body
- 2025 Guidelines for Fluorescence Image-guided Surgery Using Indocyanine Green in Gastrointestinal Procedures - A SAGES Publication
- Intraoperative fluorescence angiography with indocyanine green to prevent anastomotic leak in rectal cancer surgery (IntAct): an unblinded randomised controlled trial - ScienceDirect
- NIR-II light in clinical oncology: opportunities and challenges | Nature Reviews Clinical Oncology
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.
